Back to search

Boston University

Understanding the diagnostic process in a rare, genetic disease: a mixed methods study of schwannomatosis

Abstract

dc:description.abstract

Diagnostic errors are relatively common in medicine and can cause significant patient harm. We adapted the National Academy of Medicine’s model of the diagnostic process to examine diagnostic errors in schwannomatosis, a rare, genetic syndrome in which patients commonly develop multiple nerve sheath tumors and chronic pain. We specifically assessed how well the schwannomatosis diagnostic process currently functions; identified specific failures in the diagnostic process and assessed their contribution to diagnostic error; and explored the impact of diagnostic errors on patients’ lives. In study one, we reviewed the medical records of 97 schwannomatosis patients seen in two tertiary care clinics to assess the extent of diagnostic error in this population. It took a median of 7.9 years from patients’ first sign/symptom for a diagnosis of schwannomatosis to be established and communicated to patients. One-fifth of patients had a clear missed opportunity for appropriate workup that could have led to an earlier diagnosis. About one-third of patients experienced a misdiagnosis of their pain etiology, tumor pathology, or underlying genetic diagnosis. In study two, we created narrative summaries detailing patients’ diagnostic journeys using the medical record data of 52 schwannomatosis patients included in study one. Directed content analysis of these summaries identified the specific diagnostic process failures patients experience. Almost all patients experienced at least one failure, which most commonly reflected deficiencies in diagnostic testing, the clinical history/interview, or follow-up. Two-thirds of failures significantly impacted patient outcomes, most often by delaying needed diagnostic workup and communication of a final diagnosis to the patient. In study three, we interviewed 18 people with schwannomatosis from across the United States and used thematic analysis to explore patients’ symptom appraisal and the personal impact of diagnostic errors. Participants and their healthcare providers often ascribed schwannomatosis symptoms to more common conditions, which could delay care-seeking and initial workup. Diagnostic delay and misdiagnosis could result in unnecessary surgery, delayed receipt of effective pain management, psychological distress, and stigmatization. Collectively, these studies give unique insight into the prevalence, causes and ramifications of diagnostic error in schwannomatosis, and highlight opportunities to improve the diagnostic process across rare, genetic diseases.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Health Services Research
Grantor
Boston University
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Merker, Vanessa Leigh
Advisor dc:contributor.advisor
  • Elwy, Anashua R.

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/34802

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Merker, Vanessa Leigh. Understanding the diagnostic process in a rare, genetic disease: a mixed methods study of schwannomatosis. doctoral thesis, Boston University, 2019. https://hdl.handle.net/2144/34802